Weekly updateCompaniesRecruiting servicePost a job


    Company info:

  • 1-50
  • 2022
  • San Francisco, CA
  • 100-500M



Claim company profile

About company:

Septerna is developing drugs against G-protein coupled receptors (GPCRs). GPCRs are found at the cell membrane and have proven to be the most ‘druggable’ class of proteins. However, many remain ‘undruggable’. Septerna is addressing this problem using their Native Complex platform to design a new era of GPCR-targeted medicines. The platform recapitulates the native structure, function and dynamics of GPCRs, thus enabling structure-based drug design and large-scale screening. Drug hits are further examined with Cryo-EM and optimized through in silico approaches. Due to the prolific nature of GPCRs, Septerna’s diversified portfolio spans multiple therapeutic areas.


Director, Scientific Computing
San Francisco, CA|17 days ago
Associate Scientist, Protein Science
San Francisco, CA|41 days ago
Director of Molecular Pharmacology, Discovery Biology
South San Francisco, CA/ On-site|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com